{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:08:54Z","timestamp":1753891734278,"version":"3.41.2"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["19-0411, 15-0086"],"award-info":[{"award-number":["19-0411, 15-0086"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["1\/0327\/19"],"award-info":[{"award-number":["1\/0327\/19"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Testicular germ cell tumors (GCTs) are malignancies with a unique biology, pathology, clinical appearance, and excellent outcomes. A correct radiographic assessment of GCTs is extremely important for the clinical management in several typical scenarios. Advancements in the field of diagnostic medicine bring an increasing number of sophisticated imaging methods to increase the performance of imaging studies. The conventional computed tomography (CT) remains the mainstay of diagnostic imaging in the management of GCTs. While certain improvements in the sensitivity and specificity are suggested with magnetic resonance (MR) imaging with lymphotrophic nanoparticles in evaluating retroperitoneal lymph nodes during the staging procedure, further exploration in larger prospective studies is needed. A common diagnostic dilemma is assessing the post-chemotherapy residual disease in GCTs. Several studies have consistently shown advantages in the utility of positron emission tomography (PET) scanning in post-chemotherapy residual retroperitoneal lymph nodes in patients with seminoma, but not with non-seminoma. Recommendations suggest that seminoma patients with a residual disease in the retroperitoneum larger than 3\u00a0cm should be subjected for PET scanning with 18-fluorodeoxyglucose. Relatively high sensitivity, specificity and a negative predictive value (80\u201395%) may guide clinical decision to spare these patients of high morbidity of an unnecessary surgery. However, a positive predictive value of around 50% renders PET scanning difficult to interpret in the case of positive finding. These patients often require extremely difficult surgical procedures with the high risk of post-operative morbidity. Therefore, seminoma patients with PET positive residual masses larger than 3\u00a0cm still remain a serious challenge in the decision making of nuclear medicine specialist, oncologists, and urologic surgeons. In this article, we aim to summarize data on controversial dilemmas in staging procedures, active surveillance, and post-chemotherapy assessment of GCTs based on the available published literature.<\/jats:p>","DOI":"10.3389\/fonc.2020.587523","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T04:55:50Z","timestamp":1609822550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Intricacies of Radiographic Assessment in Testicular Germ Cell Tumors"],"prefix":"10.3389","volume":"10","author":[{"given":"Marek","family":"Makovn\u00edk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katar\u00edna","family":"Rejlekov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Uhrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Mego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Chovanec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp530","article-title":"Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975","volume":"21","author":"La Vecchia","year":"2010","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6941.1393","article-title":"Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise","volume":"308","author":"Forman","year":"1994","journal-title":"Bmj"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx731","article-title":"Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors","volume":"29","author":"Albany","year":"2018","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on Testicular Cancer: 2015 Update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.10319","article-title":"Testicular cancer: what the radiologist needs to know","volume":"200","author":"Kreydin","year":"2013","journal-title":"Am J Roentgenol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/0970-1591.60450","article-title":"Prognostic features and markers for testicular cancer management","volume":"26","author":"Leman","year":"2010","journal-title":"Indian J Urol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.324","article-title":"Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance","volume":"4","author":"Chung","year":"2015","journal-title":"Cancer Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/0970-1591.60451","article-title":"Update on management of seminoma","volume":"26","author":"Alexander","year":"2010","journal-title":"Indian J Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.07.169","article-title":"Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial","volume":"21","author":"Albers","year":"2003","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.2.358","article-title":"Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma\u2013predominant testis cancer","volume":"18","author":"Sweeney","year":"2000","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International germ cell cancer collaborative group prognostic factor scoring system","volume":"15","author":"Mead","year":"1997","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz249.002","article-title":"Redefining the IGCCCG classification in advanced non-seminoma","volume":"30","author":"Gillessen","year":"2019","journal-title":"Ann Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2758","article-title":"The role of imaging in the diagnosis, staging, and management of testicular cancer","volume":"191","author":"Sohaib","year":"2008","journal-title":"Am J Roentgenol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/00003072-198612000-00004","article-title":"Lymphoscintigraphic studies of lymphatic drainage from the testes","volume":"11","author":"Yeh","year":"1986","journal-title":"Clin Nucl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2016.164","article-title":"Management of stage I testicular germ cell tumours","volume":"13","author":"Chovanec","year":"2016","journal-title":"Nat Rev Urol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22898","article-title":"Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor","volume":"110","author":"Beck","year":"2007","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2018.00080","article-title":"Preservation of Ejaculatory Function After Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) in Patients With Testicular Cancer: Template vs. Bilateral Resection","volume":"5","author":"Hiester","year":"2018","journal-title":"Front Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00218","article-title":"Severe complications in testicular germ cell tumors: the choriocarcinoma syndrome","volume":"10","author":"Rejlekova","year":"2019","journal-title":"Front Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/1066896911431452","article-title":"Correlation between retroperitoneal lymph node size and presence of metastases in nonseminomatous germ cell tumors","volume":"20","author":"Hudolin","year":"2012","journal-title":"Int J Surg Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.169.2.9242768","article-title":"CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria","volume":"169","author":"Hilton","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-5994.2003.00456.x","article-title":"Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow up","volume":"33","author":"Karapetis","year":"2003","journal-title":"Internal Med J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2002.02641.x","article-title":"The role of 18fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours","volume":"89","author":"Spermon","year":"2002","journal-title":"BJU Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66778-8","article-title":"Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes","volume":"154","author":"Leibovitch","year":"1995","journal-title":"J Urol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt304","article-title":"Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Oldenburg","year":"2013","journal-title":"Ann Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2008.10.011","article-title":"Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours","volume":"64","author":"Sohaib","year":"2009","journal-title":"Clin Radiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.166","article-title":"Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer","volume":"23","author":"Rockall","year":"2004","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.172.5.10227514","article-title":"MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation","volume":"172","author":"Harisinghani","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.05.049","article-title":"A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation","volume":"66","author":"Harisinghani","year":"2005","journal-title":"Urology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10494","article-title":"Prospective comparison of [18F] fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma","volume":"94","author":"Kollmannsberger","year":"2002","journal-title":"Cancer: Interdiscip Int J Am Cancer Soc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/annonc\/mdr052","article-title":"2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial","volume":"23","author":"Bachner","year":"2012","journal-title":"Ann Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6742-9","article-title":"Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell Tumor","volume":"25","author":"Toyoshima","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(87)90174-0","article-title":"Bleomycin-induced pulmonary nodules: a variant of bleomycin pulmonary toxicity","volume":"28","author":"Zucker","year":"1987","journal-title":"Gynecol Oncol"},{"key":"B33","article-title":"Predopera\u010dn\u00e9 MR a CT mozgov\u00fdch n\u00e1dorov","volume":"2","author":"Belan","year":"2007","journal-title":"Onkol\u00f3gia (Bratisl)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0058","article-title":"for the National Comprehensive Cancer Network Testicular Cancer Panel. Testicular cancer","volume":"13","author":"Motzer","year":"2015","journal-title":"NCCN Pract Guidelines Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/BF00817273","article-title":"Imaging metastatic testicular germ cell tumours with 18 FDG positron emission tomography: prospects for detection and management","volume":"22","author":"Wilson","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn170","article-title":"[18F]-FDG\u2013PET in clinical stage I\/II non-seminomatous germ cell tumours: results of the German multicentre trial","volume":"19","author":"De Wit","year":"2008","journal-title":"Ann Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1159\/000049823","article-title":"Diagnosis and monitoring of urological tumors using positron emission tomography","volume":"40","author":"Hofer","year":"2001","journal-title":"Eur Urol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00576-7","article-title":"Positron emission tomography in the clinical staging of patients with stage I and II testicular germ cell tumors","volume":"53","author":"Albers","year":"1999","journal-title":"Urology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000303","article-title":"The role of 18F-FDG PET\/CT in the management of testicular cancers","volume":"36","author":"Cook","year":"2015","journal-title":"Nucl Med Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050547","article-title":"Fluorodeoxyglucose positron emission tomography in the initial staging of germ cell tumours","volume":"27","author":"Hain","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"852681","DOI":"10.1155\/2014\/852681","article-title":"Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in the Postchemotherapy Management of Patients with Seminoma: Systematic Review and Meta-Analysis","volume":"2014","author":"Treglia","year":"2014","journal-title":"BioMed Res Int"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00210","article-title":"Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry","volume":"36","author":"Cathomas","year":"2018","journal-title":"J Clin Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds579","article-title":"Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer","volume":"24","author":"Beyer","year":"2013","journal-title":"Ann Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.eururo.2008.03.017","article-title":"European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II","volume":"53","author":"Krege","year":"2008","journal-title":"Eur Urol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s00259-002-1075-z","article-title":"Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours","volume":"30","author":"Lassen","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.5.1637","article-title":"Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients","volume":"14","author":"Stephens","year":"1996","journal-title":"J Clin Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.1157","article-title":"[18F] Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group","volume":"26","author":"Oechsle","year":"2008","journal-title":"J Clin Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.211.1.r99ap16249","article-title":"Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling","volume":"211","author":"Sugawara","year":"1999","journal-title":"Radiology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-003-0392-6","article-title":"The role of [18 F] FDG-PET, CT\/MRI and tumor marker kinetics in the evaluation of postchemotherapy residual masses in metastatic germ cell tumors\u2014prospects for management","volume":"22","author":"Pfannenberg","year":"2004","journal-title":"World J Urol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.07.024","article-title":"18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy","volume":"64","author":"Putra","year":"2004","journal-title":"Urology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi915","article-title":"FDG-PET in the management of germ cell tumor","volume":"16","author":"De Giorgi","year":"2005","journal-title":"Ann Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e16535","DOI":"10.1200\/JCO.2018.36.15_suppl.e16535","article-title":"A pilot study to assess the accuracy of \u201cintuition\u201d in analyzing post chemotherapy (chemo) residual retroperitoneal (RP) masses in patients (pts) with non seminomatous germ cell tumor (NSCGCT)","volume":"36","author":"Cary","year":"2018","journal-title":"Am Soc Clin Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"6783147","DOI":"10.1155\/2018\/6783147","article-title":"The Use of Modified Templates in Early and Advanced Stage Nonseminomatous Germ Cell Tumor","volume":"2018","author":"Masterson","year":"2018","journal-title":"Adv Urol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.09.027","article-title":"Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection","volume":"55","author":"Heidenreich","year":"2009","journal-title":"Eur Urol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-87-3-293","article-title":"Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer","volume":"87","author":"Einhorn","year":"1977","journal-title":"Ann Intern Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.e16059","article-title":"Improved outcomes in testicular germ cell tumor patients treated at the referral center in Slovakia in the last decade","volume":"37","author":"Chovanec","year":"2019","journal-title":"J Clin Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq177","article-title":"Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Schmoll","year":"2010","journal-title":"Ann Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji278","article-title":"Second cancers among 40 576 testicular cancer patients: focus on long-term survivors","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.4889","article-title":"Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197\u2014the National Cancer Research Institute Testis Cancer Clinical Studies Group","volume":"25","author":"Rustin","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.6379","article-title":"Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer","volume":"29","author":"van Walraven","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.587523\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T04:55:53Z","timestamp":1609822553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.587523\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":60,"alternative-id":["10.3389\/fonc.2020.587523"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.587523","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"article-number":"587523"}}